News AMD: Brolucizumab Noninferior to Aflibercept in Early Study by Medscape • 2017/09/18 • 0 Comments A small phase 2 study suggests that brolucizumab is as safe and effective as aflibercept for treating patients with age-related macular degeneration. Medscape Medical News Full Story →